We are looking specifically at diagnostics – NICE Guidance – DG34 – tumour profiling for breast cancer, as a recent example. We would like to understand any procurement plans you have in place as a result of this? Including dates, procurement route (open, restricted), regime (whether light touch regime, standard OJEU), likely weightings (quality vs price), or via NHS Supply Chain or other framework provider?